Rexford Capital Inc Astrazeneca PLC Transaction History
Rexford Capital Inc
- $121 Billion
- Q2 2025
A detailed history of Rexford Capital Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Rexford Capital Inc holds 13,566 shares of AZN stock, worth $1.16 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
13,566Holding current value
$1.16 Million% of portfolio
0.79%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.43 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.51 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.93 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.68 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.66 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $264B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...